We just received data on a new analyst forecast for $EMR. Nicole Deblase from Deutsche Bank set a price target of 170.0 for EMR.
To track analyst ratings and price targets for $EMR, check out Quiver Quantitative's $EMR forecast page.
Should you buy $EMR?
Some analysts are better than others. To view the past performance of Deutsche Bank, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$EMR Price Targets
Multiple analysts have issued price targets for $EMR recently. We have seen 9 analysts offer price targets for $EMR in the last 6 months, with a median target of $160.0.
Here are some recent targets:
- Nicole Deblase from Deutsche Bank set a target price of $170.0 on 02/05/2026
- Joseph O'Dea from Wells Fargo set a target price of $160.0 on 02/04/2026
- Andrew Kaplowitz from Citigroup set a target price of $174.0 on 02/04/2026
- Stephen Tusa from JP Morgan set a target price of $157.0 on 01/16/2026
- Julian Mitchell from Barclays set a target price of $145.0 on 01/07/2026
- Amit Mehrotra from UBS set a target price of $168.0 on 01/05/2026
- Alexander Virgo from Evercore ISI Group set a target price of $170.0 on 12/15/2025
$EMR Insider Trading Activity
$EMR insiders have traded $EMR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:
- SURENDRALAL LANCA KARSANBHAI (President & CEO) sold 7,263 shares for an estimated $965,979
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EMR Revenue
$EMR had revenues of $4.3B in Q1 2026. This is an increase of 4.1% from the same period in the prior year.
You can track EMR financials on Quiver Quantitative's EMR stock page.
$EMR Congressional Stock Trading
Members of Congress have traded $EMR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$EMR Hedge Fund Activity
We have seen 841 institutional investors add shares of $EMR stock to their portfolio, and 977 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 8,823,166 shares (+70.4%) to their portfolio in Q3 2025, for an estimated $1,157,422,915
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,770,848 shares (+85.0%) to their portfolio in Q3 2025, for an estimated $494,659,840
- STIFEL FINANCIAL CORP removed 3,259,854 shares (-76.7%) from their portfolio in Q3 2025, for an estimated $427,627,647
- BANK OF AMERICA CORP /DE/ removed 2,465,183 shares (-12.9%) from their portfolio in Q3 2025, for an estimated $323,382,705
- AMERIPRISE FINANCIAL INC added 2,075,425 shares (+185.7%) to their portfolio in Q3 2025, for an estimated $272,254,251
- CAPITAL WORLD INVESTORS removed 1,532,420 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $201,022,855
- 1832 ASSET MANAGEMENT L.P. added 1,481,481 shares (+109.3%) to their portfolio in Q3 2025, for an estimated $194,340,677
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.